Enanta Pharmaceuticals (ENTA) Assets Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.62% |
| Dec 31, 2025 | -7.29% |
| Sep 30, 2025 | -10.40% |
| Jun 30, 2025 | -10.07% |
| Mar 31, 2025 | -8.86% |
| Dec 31, 2024 | -7.36% |
| Sep 30, 2024 | -5.12% |
| Jun 30, 2024 | -3.37% |
| Mar 31, 2024 | -2.17% |
| Dec 31, 2023 | -1.16% |
| Sep 30, 2023 | 2.22% |
| Jun 30, 2023 | 5.49% |
| Mar 31, 2023 | -1.64% |
| Dec 31, 2022 | 0.40% |
| Sep 30, 2022 | 2.82% |
| Jun 30, 2022 | 6.91% |
| Mar 31, 2022 | 7.84% |
| Dec 31, 2021 | 9.62% |
| Sep 30, 2021 | 9.30% |
| Jun 30, 2021 | 9.82% |
| Mar 31, 2021 | 10.68% |
| Dec 31, 2020 | 11.56% |
| Sep 30, 2020 | 14.59% |
| Jun 30, 2020 | 16.57% |
| Mar 31, 2020 | 15.87% |
| Dec 31, 2019 | 18.86% |
| Sep 30, 2019 | 25.81% |
| Jun 30, 2019 | 24.31% |
| Mar 31, 2019 | 33.62% |
| Dec 31, 2018 | 32.75% |
| Sep 30, 2018 | 28.77% |
| Jun 30, 2018 | 25.94% |
| Mar 31, 2018 | 23.07% |
| Sep 30, 2017 | 44.33% |